AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
$23.69 0.15 (0.6372%)
Analysed AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) News Sources
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
30-07-2026
yahoo.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Posts Better-Than-Expected Sales In Q2 CY2026
06-08-2026
yahoo.com
Amphastar Pharmaceuticals Q2 Earnings Call Highlights
06-08-2026
marketbeat.com
Compared to Estimates, Amphastar (AMPH) Q2 Earnings: A Look at Key Metrics
06-08-2026
yahoo.com
AMPH Q2 Deep Dive: Portfolio Expansion and Pipeline Progress Drive Results
11-08-2026
yahoo.com
Amphastar (AMPH) Q2 2026 Earnings Call Transcript
14-08-2026
fool.com
The Top 5 Analyst Questions From Amphastar Pharmaceuticals’s Q2 Earnings Call
15-08-2026
yahoo.com
Amphastar Pharmaceuticals to Present at the Wells Fargo 21st Annual Healthcare Conference
01-09-2026
yahoo.com
Amphastar Pharmaceuticals (AMPH) Stock Looks Cheap With Earnings Doing The Heavy Lifting
05-09-2026
yahoo.com
Amphastar Pharmaceuticals (AMPH) Rebounds In Focus, Is It Slightly Overvalued?
06-09-2026
yahoo.com
What is the current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The current price of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is $23.69.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is $0.15.
AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) since the previous trading day is 0.6372%.
What is the most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent average sentiment score for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)?
The most recent sentiment for AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ) is .
SEC-8K** Filing Available For AMPHASTAR PHARMACEUTICALS IN (AMPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.